Purple Innovation, Inc. Common Stock PRPL
$6.82
+3.33%
at last close
Analyst Consensus
- Consensus Rating
- Hold (0 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $0.65
- Implied Upside
- -90.5%
- Price Target Range
- $0.65 – $0.65
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-29 | UBSDan Silverstein |
Maintains | Neutral | $1 → $1 |
| 2026-04-29 | KeybancBradley B. Thomas |
Downgrades | Overweight → Sector weight | — |
| 2026-04-01 | UBSDan Silverstein |
Maintains | Neutral | $1 → $1 |
| 2025-03-26 | WedbushSeth Basham |
Reiterates | Neutral | $1 |
| 2024-09-04 | WedbushSeth Basham |
Downgrades | Outperform → Neutral | $2 → $1 |
| 2024-08-06 | Craig-HallumJeremy Hamblin |
Maintains | Hold | $2 → $2 |
| 2024-05-08 | WedbushSeth Basham |
Reiterates | Outperform | $2 |
| 2024-03-21 | Roth MKMMatt Koranda |
Reiterates | Buy | $3 |
| 2024-03-13 | Roth MKMMatt Koranda |
Upgrades | Neutral → Buy | $2 → $3 |
| 2024-03-13 | Craig-HallumJeremy Hamblin |
Maintains | Hold | $1 → $2 |
| 2024-03-13 | WedbushSeth Basham |
Maintains | Outperform | $1 → $2 |
| 2024-03-07 | Roth MKMMatt Koranda |
Maintains | Neutral | $1 → $2 |
| 2024-01-24 | WedbushSeth Basham |
Reiterates | Outperform | $1 |
| 2024-01-24 | KeybancBradley Thomas |
Maintains | Overweight | $6 → $5 |
| 2023-11-13 | OppenheimerBrian Nagel |
Downgrades | Outperform → Perform | — |
| 2023-11-10 | Craig-HallumJeremy Hamblin |
Downgrades | Buy → Hold | — |
| 2023-11-10 | WedbushSeth Basham |
Maintains | Outperform | $3 → $1 |
| 2023-11-10 | KeybancBradley Thomas |
Maintains | Overweight | $8 → $6 |
| 2023-08-25 | OppenheimerBrian Nagel |
Reiterates | Outperform | $8 |
| 2023-08-10 | WedbushSeth Basham |
Maintains | Outperform | $4 → $3 |
| 2023-04-14 | WedbushSeth Basham |
Reiterates | Outperform | $5 |
| 2023-03-21 | UBSAtul Maheswari |
Maintains | Neutral | $6 → $3 |
| 2023-02-01 | KeybancBradley Thomas |
Maintains | Overweight | $7 → $8 |
| 2023-01-12 | KeybancAleksey Yefremov |
Maintains | Overweight | $5 → $7 |
| 2022-11-10 | Craig-HallumJeremy Hamblin |
Upgrades | Hold → Buy | $4 → $6 |
| 2022-09-20 | WedbushSeth Basham |
Maintains | Outperform | $3 → $5 |
| 2022-09-20 | KeybancBradley Thomas |
Maintains | Overweight | $10 → $5 |
| 2022-03-28 | KeybancBradley Thomas |
Maintains | Overweight | $16 → $15 |
| 2022-03-02 | Roth CapitalMatt Koranda |
Downgrades | Buy → Neutral | $6 |
| 2022-03-02 | KeybancBradley Thomas |
Maintains | Overweight | $22 → $16 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.82
- Market Cap
- $29.73 million
- 52-Week Range
- $6.12 – $31.50
- Average Volume
- 27K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.